MAGGI, CLAUDIA

MAGGI, CLAUDIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 2019 Vernieri, ClaudioPrisciandaro, MicheleMaggi, ClaudiaMennitto, AlessiaFabbroni, ChiaraFarè, Elenade Braud, Filippo + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials 2016 F. PietrantonioC. MaggiF. de Braud + Article (author) -
Treatment of elderly patients with metastatic renal cell carcinoma 2016 E. VerzoniC. MaggiF. De Braud + Article (author) -
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 2016 F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + Article (author) -
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer 2016 F. PietrantonioF. de BraudC. MaggiK.F. DottiA. Pellegrinelli + Article (author) -
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer 2015 C. MaggiF. RicchiniF. PietrantonioF. de Braud + Article (author) -
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 2015 F. PietrantonioF. PetrelliM. Di BartolomeoC. MaggiF. de Braud + Article (author) -
In reply 2015 C. MaggiF. DebraudF. Pietrantonio + Article (author) -
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab 2015 V. MusellaF. PietrantonioC. MaggiF. de Braud + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 2015 F. PietrantonioV. MazzaferroCOTSOGLOU, CHRISTIANG. FanettiP. BiondaniC. MaggiF. de Braud + Article (author) -
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab : a meta-analysis 2015 F. PietrantonioK. BorgonovoC. MaggiF. De Braud + Article (author) -
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer : an Italian Trials of Medical Oncology phase II study 2015 F. PietrantonioK. F. DottiC. Maggi + Article (author) -
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 2015 F.S. FalvellaS. CheliC. MaggiM. NigerF. RicchiniI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies 2014 F. PietrantonioC. MaggiF. RicchiniF. De Braud + Article (author) -
Role of MGMT as biomarker in colorectal cancer 2014 G. FanettiC. MaggiF. de BraudF. Pietrantonio + Article (author) -
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 2014 F. PietrantonioF. PerroneF. De BraudC. MaggiGEVORGYAN, ARPINEP. BiondaniF. Festinese + Article (author) -
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 2014 F. PietrantonioC. MaggiG. FanettiF. RicchiniI. BossiG. PelosiF. de Braud + Article (author) -
TP53 mutations in advanced colorectal cancer : the dark side of the moon 2014 F. PietrantonioP. BiondaniC. MaggiI. BossiF. De Braud + Article (author) -